Skip to main content
. 2011 Apr 25;6(4):e18572. doi: 10.1371/journal.pone.0018572

Table 4. Treatment characteristics.

No Study HSCT; N. treated/N. total (%) IST; N. treated/N. total (%)
Irradiation* ATG or ALG ATG or ALG CSA
1 Ahn 2003 [31] 6/64 (9) 53/64 (83) 148/156 (95) 67/156 (43)
2 Arranz 1994 [32] 20/21 (95) 29/29 (100) 0
3 Bacigalupo 1988 [33] 110/218 (50) 291/291 (100) 0
4 Bacigalupo 2000 [34] 433/1759 (25) 28/1759 (2)
5 Bayever 1984 [35] 35/35 (100) 0 22/22 (100) 0
6 Champlin 1984 [36] 59/61 (97) 0 69/69 (100) 0
7 De Planque 1990 [37] 15/19 (79) 1/19 (5) 83/83 (100) 0
8 Doney 1997 [38] 0 21/168 (24) 225/227 (99) 1/227 (1)
9 Fouladi 2000 [39] 12/21 (57) 5/21 (24) 20/20 (100) 19/20 (95)
10 Führer 1998 [40] 28/28 (100) 86/86 (100) 86/86 (100)
11 Führer 2005 [41] 0 0 VSAA: 97/97 (100) VSAA: 97/97 (100)
SAA: 49/49 (100) SAA: 49/49 (100)
12 Ghavamzadeh 2004 [42] 0 29/29 (100) 2/24 (8) 24/24 (100)
13 Gillio 1997 [43] 17/25 (68) 3/25 (12) 23/23 (100) 0
14 Gluckman 1979 [44] 10/37 (27) 9/37 (24) 28/28 (100) 0
15 Halperin 1989 [45] 14/14 (100) 14/14 (100) 12/12 (100) 0
16 Kahn 2002 [46] 8/15 (53) 0 16/16 (100) 16/16 (100)
17 Kim 2003 [47] 17/22 (77) 2/22 (9) 74/74 (100) 17/74 (23)
18 Kojima 2000 [48] 26/37 (70) 9/37 (24) 27/63 (43) 2/63 (3)
19 Lawlor 1997 [49] 2/9 (22) 1/9 (11) 18/18 (100) 15/18 (83)
20 Locasciulli 1990 [50] 59/171 (35) 34/171 (20) 133/133 (100) 0
21 Locasciulli 2007 [51] 282/1567 (18) 319/1567 (20) 495/912 (54) 846/912 (93)
22 Paquette 1995 [52] 1977–1983: 40/40 (100) 0
1984–1989: 16/16 (100)
23 Pitcher 1999 [53] 1973–1988: 18/18 (100) 1973–1988: 0
1989–1996: 25/25 (100) 1989–1996: 14/25 (56)
24 Tzeng 1989 [54] 9/9 (100) 0 7/7 (100) 0
25 Viollier 2005 [55] 155/155 (100) 0
26 Werner 1989 [56] 2/6 (33) 8/9 (89) 2/9 (22)

*Irradiation: conditioning irradiation: thoraco-abdominal irradiation, total body irradiation, or total lymphoid irradiation.

Abbreviations: ALG: anti-lymphocyte globulin; ATG: anti-thymocyte globulin; CSA: cyclosporine A; HSCT: hematopoietic stem cell transplantation; IST: immunosuppressive therapy.